Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2010 1
2011 1
2012 5
2013 6
2014 1
2015 3
2016 1
2018 1
2020 1
2022 1
2023 1
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

22 results

Results by year

Filters applied: . Clear all
Page 1
Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial.
Zhu AX, Finn RS, Edeline J, Cattan S, Ogasawara S, Palmer D, Verslype C, Zagonel V, Fartoux L, Vogel A, Sarker D, Verset G, Chan SL, Knox J, Daniele B, Webber AL, Ebbinghaus SW, Ma J, Siegel AB, Cheng AL, Kudo M; KEYNOTE-224 investigators. Zhu AX, et al. Lancet Oncol. 2018 Jul;19(7):940-952. doi: 10.1016/S1470-2045(18)30351-6. Epub 2018 Jun 3. Lancet Oncol. 2018. PMID: 29875066 Clinical Trial.
Diabetes and pancreatic cancer.
Chaudhry ZW, Hall E, Kalyani RR, Cosgrove DP, Yeh HC. Chaudhry ZW, et al. Among authors: cosgrove dp. Curr Probl Cancer. 2013 Sep-Oct;37(5):287-92. doi: 10.1016/j.currproblcancer.2013.10.006. Epub 2013 Oct 8. Curr Probl Cancer. 2013. PMID: 24331184 Review. No abstract available.
Hilar cholangiocarcinoma: diagnosis, treatment options, and management.
Soares KC, Kamel I, Cosgrove DP, Herman JM, Pawlik TM. Soares KC, et al. Among authors: cosgrove dp. Hepatobiliary Surg Nutr. 2014 Feb;3(1):18-34. doi: 10.3978/j.issn.2304-3881.2014.02.05. Hepatobiliary Surg Nutr. 2014. PMID: 24696835 Free PMC article. Review.
The PIK3CA gene as a mutated target for cancer therapy.
Gustin JP, Cosgrove DP, Park BH. Gustin JP, et al. Among authors: cosgrove dp. Curr Cancer Drug Targets. 2008 Dec;8(8):733-40. doi: 10.2174/156800908786733504. Curr Cancer Drug Targets. 2008. PMID: 19075596 Free PMC article. Review.
Neuroendocrine tumor liver metastases treated with yttrium-90 radioembolization.
Fan KY, Wild AT, Halappa VG, Kumar R, Ellsworth S, Ziegler M, Garg T, Rosati LM, Su Z, Hacker-Prietz A, Pawlik TM, Cosgrove DP, Hong KK, Kamel IR, Geschwind JF, Herman JM. Fan KY, et al. Among authors: cosgrove dp. Contemp Clin Trials. 2016 Sep;50:143-9. doi: 10.1016/j.cct.2016.08.001. Epub 2016 Aug 9. Contemp Clin Trials. 2016. PMID: 27520932
Image of the month. Recurrent metastatic HCC.
Kneuertz PJ, Malla M, Cosgrove DP, Herman JM, Kamel IR, Geschwind JF, Cameron AM, Pawlik TM. Kneuertz PJ, et al. Among authors: cosgrove dp. Arch Surg. 2012 Oct;147(10):974. doi: 10.1001/archsurg.147.10.974. Arch Surg. 2012. PMID: 23070415 Free PMC article. No abstract available.
PIK3CA mutations and EGFR overexpression predict for lithium sensitivity in human breast epithelial cells.
Higgins MJ, Beaver JA, Wong HY, Gustin JP, Lauring JD, Garay JP, Konishi H, Mohseni M, Wang GM, Cidado J, Jelovac D, Cosgrove DP, Tamaki A, Abukhdeir AM, Park BH. Higgins MJ, et al. Among authors: cosgrove dp. Cancer Biol Ther. 2011 Feb 1;11(3):358-67. doi: 10.4161/cbt.11.3.14227. Epub 2011 Feb 1. Cancer Biol Ther. 2011. PMID: 21124076 Free PMC article.
22 results